Outsourcing-Pharma: Altasciences Eyes Early Development Space, CDMO Addition
Altasciences eyes early development space, CDMO addition
By Melissa Fassbender
Consolidating its businesses under one brand, Altasciences is transitioning to an early drug development CRO – and looking to add a CDMO to manufacture drugs up to Phase II volumes.